Ignite Creation Date:
2024-05-05 @ 6:31 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00498992
Status:
UNKNOWN
Last Update Posted:
2013-09-20
First Post:
2007-07-10
Brief Title:
Regenecare Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Sponsor:
Ingalls Memorial Hospital
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000553120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ingalls Memorial Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None